These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7501028)

  • 21. The elderly donor.
    Lloveras J
    Transplant Proc; 1991 Oct; 23(5):2592-5. PubMed ID: 1926494
    [No Abstract]   [Full Text] [Related]  

  • 22. [Italian Registry of Dialysis and Transplantation: 1996-2001 experience].
    Conte F; Cappelli G; Casino F; Postorino M; Quintaliani G; Salomone M; Di Napoli A; Limido A; Mancini E; Nordio M; Pinna A; Santoro D; Alloatti S; Bellinghieri G; Bonadonna A; Bonomini M; Colasanti G; Di Giulio S; Di Iorio B; Di Lallo D; Gaffi G; Gesualdo L; Locatelli F; Piccoli G; Quarello F; Riegler P; Salvadori M; Santoro A; Sparano G; Vasile A;
    G Ital Nefrol; 2004; 21(6):561-7. PubMed ID: 15593024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ESRD in children.
    Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):79-88. PubMed ID: 1951360
    [No Abstract]   [Full Text] [Related]  

  • 24. [The survival of patients with chronic kidney failure].
    Buchard F
    Nouv Presse Med; 1974 Apr; 3(17):1097-100. PubMed ID: 4601992
    [No Abstract]   [Full Text] [Related]  

  • 25. Hospitalizations for bacterial septicemia in patients with end stage renal disease due to diabetes on the renal transplant waiting list.
    Abbott KC; Napier MG; Agodoa LY
    J Nephrol; 2002; 15(3):248-54. PubMed ID: 12113595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment modalities for ESRD patients. United States Renal Data System.
    Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S50-9. PubMed ID: 9713407
    [No Abstract]   [Full Text] [Related]  

  • 27. Annual facility survey of providers of ESRD therapy. United States Renal Data System.
    Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S132-5. PubMed ID: 9713415
    [No Abstract]   [Full Text] [Related]  

  • 28. By (all) the numbers...? Latest USRDS report draws from new sources to help close the data gap.
    Neumann ME
    Nephrol News Issues; 2002 Nov; 16(12):65-9, 72. PubMed ID: 12452111
    [No Abstract]   [Full Text] [Related]  

  • 29. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of dialysis and transplant registries to clinical practice: the Lombardy Registry.
    Locatelli F; Tentori F; Del Vecchio L; Pontoriero G
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii2-4. PubMed ID: 15192126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing the supply of kidneys for transplantation.
    O'Connor KJ; Delmonico FL
    Semin Dial; 2005; 18(6):460-2. PubMed ID: 16398706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Part III: Vascular access and anemia management. Inching up. Annual sampling of clinical indicators for ESRD patients shows continuing improvement.
    Nephrol News Issues; 2002 May; 16(6):25-8. PubMed ID: 12035623
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal replacement therapy in Egypt: first annual report of the Egyptian Society of Nephrology, 1996.
    Afifi A; Karim MA
    East Mediterr Health J; 1999 Sep; 5(5):1023-9. PubMed ID: 10983543
    [No Abstract]   [Full Text] [Related]  

  • 34. Organ donation and transplantation. Understanding the basics.
    Thomas C
    Diabetes Self Manag; 2005; 22(6):92, 94-6. PubMed ID: 16355475
    [No Abstract]   [Full Text] [Related]  

  • 35. Demographic and organizational developments of maintenance dialysis therapies--past, present, outlook into the future.
    Jacobs C
    J Nephrol; 1999; 12 Suppl 2():S47-52. PubMed ID: 10688402
    [No Abstract]   [Full Text] [Related]  

  • 36. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States.
    Collins AJ; Kasiske B; Herzog C; Chen SC; Everson S; Constantini E; Grimm R; McBean M; Xue J; Chavers B; Matas A; Manning W; Louis T; Pan W; Liu J; Li S; Roberts T; Dalleska F; Snyder J; Ebben J; Frazier E; Sheets D; Johnson R; Li S; Dunning S; Berrini D; Guo H; Solid C; Arko C; Daniels F; Wang X; Forrest B; Gilbertson D; St Peter W; Frederick P; Eggers P; Agodoa L
    Am J Kidney Dis; 2003 Dec; 42(6 Suppl 5):A5-7, S1-230. PubMed ID: 14655179
    [No Abstract]   [Full Text] [Related]  

  • 37. 1998 U.S. Renal Data System Report/Part II. Living unrelated donor rate grew 46% annually from 1993-96; hospitalizations higher for pediatric HD vs. PD patients.
    Nephrol News Issues; 1998 Oct; 12(10):62-3. PubMed ID: 10196958
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary on the highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe.
    Viklicky O; Pokorna E; Vitko S;
    Nephrol Dial Transplant; 2006 Jul; 21(7):2025-6; author reply 2026. PubMed ID: 16735390
    [No Abstract]   [Full Text] [Related]  

  • 39. Strategies for influencing outcomes in pre-ESRD and ESRD patients.
    Burkart JM; Pereira BJ; Parker TF
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S2-3. PubMed ID: 11443764
    [No Abstract]   [Full Text] [Related]  

  • 40. How doctors are managing their kidney failure patients.
    Med World News; 1978 Apr; 19(8):68, 70. PubMed ID: 10307032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.